Ishioka C - Search Results

1

The screening of the second-site suppressor mutations of the common p53 mutants.

Otsuka K, Kato S, Kakudo Y, Mashiko S, Shibata H, Ishioka C. Otsuka K, et al. Among authors: ishioka c. Int J Cancer. 2007 Aug 1;121(3):559-66. doi: 10.1002/ijc.22724. Int J Cancer. 2007. PMID: 17417775

2

Mutations of the p53 gene and other genes involving in human colorectal carcinogenesis.

Kanamaru R, Ishioka C. Kanamaru R, et al. Among authors: ishioka c. Tohoku J Exp Med. 1992 Oct;168(2):159-66. doi: 10.1620/tjem.168.159. Tohoku J Exp Med. 1992. PMID: 1306299 Free article.

3

Mutations of the P53 gene, including an intronic point mutation, in colorectal tumors.

Ishioka C, Sato T, Gamoh M, Suzuki T, Shibata H, Kanamaru R, Wakui A, Yamazaki T. Ishioka C, et al. Biochem Biophys Res Commun. 1991 Jun 28;177(3):901-6. doi: 10.1016/0006-291x(91)90623-f. Biochem Biophys Res Commun. 1991. PMID: 1647768

4

Increase in the level of P-glycoprotein mRNA expression in multidrug-resistant K562 cell lines treated with sodium butyrate is not accompanied with erythroid differentiation.

Shibata H, Kanamaru R, Sato T, Ishioka C, Konishi Y, Ishikawa A, Wakui A, Tsuruo T. Shibata H, et al. Among authors: ishioka c. Jpn J Cancer Res. 1990 Dec;81(12):1214-7. doi: 10.1111/j.1349-7006.1990.tb02681.x. Jpn J Cancer Res. 1990. PMID: 1980493 Free PMC article.

5

Expression of glutathione S-transferase-pi messenger RNA in human esophageal cancers.

Ishioka C, Kanamaru R, Shibata H, Konishi Y, Ishikawa A, Wakui A, Sato T, Nishihira T. Ishioka C, et al. Cancer. 1991 May 15;67(10):2560-4. doi: 10.1002/1097-0142(19910515)67:10<2560::aid-cncr2820671028>3.0.co;2-m. Cancer. 1991. PMID: 2015556

6

Multidrug resistance.

Shibata H, Kanamaru R, Sato T, Ishioka C, Suzuki T, Wakui A. Shibata H, et al. Among authors: ishioka c. Sci Rep Res Inst Tohoku Univ Med. 1990 Dec;37(1-4):27-50. Sci Rep Res Inst Tohoku Univ Med. 1990. PMID: 2103657 Review. No abstract available.

7

Comparative studies on the action of 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C and of mitomycin C on cultured HL-60 cells and isolated phage and plasmid DNA.

Ishioka C, Kanamaru R, Konishi Y, Ishikawa A, Shibata H, Wakui A. Ishioka C, et al. Cancer Chemother Pharmacol. 1990;26(2):117-21. doi: 10.1007/BF02897256. Cancer Chemother Pharmacol. 1990. PMID: 2112051

8

[DNA damage and anticancer effect].

Kanamaru R, Ishioka C, Konishi Y, Ishikawa S, Shibata H, Wakui A. Kanamaru R, et al. Among authors: ishioka c. Gan To Kagaku Ryoho. 1990 Mar;17(3 Pt 2):517-23. Gan To Kagaku Ryoho. 1990. PMID: 2181939 Review. Japanese.

9

The changes in the levels of dihydrofolate reductase mRNA and its gene dosage in 5-fluorouracil-resistant L1210 cells.

Konishi Y, Kanamaru R, Ishioka C, Ishikawa A, Shibata H, Wakui A, Dei T. Konishi Y, et al. Among authors: ishioka c. Tohoku J Exp Med. 1990 May;161(1):33-42. doi: 10.1620/tjem.161.33. Tohoku J Exp Med. 1990. PMID: 2396254 Free article.

10

Mechanism of action of the synthetic imidazole compound YM 534 on human promyelocytic leukemia line HL-60 cells.

Kanamaru R, Ishioka C, Konishi Y, Ishikawa A, Shibata H, Wakui A. Kanamaru R, et al. Among authors: ishioka c. Anticancer Drug Des. 1989 Aug;4(2):137-44. Anticancer Drug Des. 1989. PMID: 2803462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters